首页> 外文OA文献 >A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

【2h】

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

机译：培美曲塞/吉西他滨/贝伐单抗或培美曲塞/卡铂/贝伐单抗在老年晚期非小细胞肺癌一线治疗中的随机II期试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Spigel David R.; Hainsworth John D.; Shipley Dianna L.; Ervin Thomas J.; Kohler Peter C.; Lubiner Eric T.; Peyton James D.; Waterhouse David M.; Burris Howard A.; Greco F. Anthony;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. [J] . Spigel DR, Hainsworth JD, Shipley DL, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2012,第1期

机译：在一系列晚期非小细胞肺癌的老年患者的一线治疗中，培养基/吉西他滨/贝伐单抗或磷酸盐/卡铂/贝伐单抗的随机期II试验。
2. A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. [J] . Spigel DR, Hainsworth JD, Shipley DL, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2012,第1期

机译：在一系列晚期非小细胞肺癌的老年患者的一线治疗中，培养基/吉西他滨/贝伐单抗或磷酸盐/卡铂/贝伐单抗的随机期II试验。
3. A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer. [J] . Spigel DR, Hainsworth JD, Shipley DL, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2012,第1期

机译：培美曲塞/吉西他滨/贝伐单抗或培美曲塞/卡铂/贝伐单抗在老年晚期非小细胞肺癌一线治疗中的随机II期试验。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. NCCTG N0821 (Alliance): A phase II first-line study of pemetrexed carboplatin and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer with good performance status [O] . Grace K. Dy, Julian R. Molina, Yingwei Qi, -1

机译：NCCTG N0821（联盟）：培美曲塞卡铂和贝伐单抗的II期一线研究对表现良好的晚期非鳞状非小细胞肺癌老年患者
7. Elderly Subset Analysis of Randomized Phase III Study Comparing Pemetrexed Plus Carboplatin with Docetaxel Plus Carboplatin as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer [O] . 2013

机译：培美曲塞加卡铂与多西他赛加卡铂作为一线治疗局部晚期或转移性非小细胞肺癌患者的随机III期研究的老年人亚组分析

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅